Drug profile · INN
cisplatin
CISPLATIN ACCORD
cisplatin (CISPLATIN ACCORD) is a dna inhibitor. Associated with Accord Healthcare Pty.. Route of administration: injection. Current US regulatory status: approved.
Drug details — cisplatin
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 7
- Programs
- 216
- Data quality
- 0.89
Quick answer
cisplatin (CISPLATIN ACCORD) is a dna inhibitor. Associated with Accord Healthcare Pty.. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
DNA inhibitor
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 11013740
Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy
granted -
US 10272084
Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy
granted -
US 8703756
Synthetic procedure and cancer treatment with cisplatin derivatives
granted -
EP 2678011
ANTITUMORIGENE KOMBINATON, DIE CABAZITAXEL UND CISPLATIN UMFASST
granted -
EP 2620148
Antitumorkombination mit Cabazitaxel und Cisplatin
granted -
EP 2491925
Antitumorigene Kombinaton, die Cabazitaxel und Cisplatin umfasst
granted -
US 7700134
Prevention of cisplatin induced deafness
granted
Frequently asked questions
What is cisplatin?
cisplatin (CISPLATIN ACCORD) is a dna inhibitor. Associated with Accord Healthcare Pty.. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for cisplatin?
CISPLATIN ACCORD is a marketed brand name for cisplatin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cisplatin?
cisplatin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.